key: cord-1006538-5ds91ckw
authors: Culebras, Esther; Hernández, Félix
title: ACE2 is on the X chromosome: could this explain COVID-19 gender differences?
date: 2020-06-24
journal: Eur Heart J
DOI: 10.1093/eurheartj/ehaa521
sha: 87f51c053b16df7c16cee973592913511717c86e
doc_id: 1006538
cord_uid: 5ds91ckw

nan

This commentary refers to 'Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensinaldosterone inhibitors', by I.E. Sama et al., 2020;41:1810-1817.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the resulting disease termed coronavirus disease 2019 (COVID-19) shows a fatality rate greater in men compared with women. 1 To explain this, some hypotheses have been raised, from genes that regulate the immune system encoded on the X chromosome to smoking behaviour, 2 to expression levels 1 or variants for angiotensinconverting enzyme 2 (ACE2), the receptor for SARS-CoV-2. 3 However, we would like to point out that the ACE2 gene is located on the X chromosome (location: Xp22.2; nucleotides 15 494 402-15 602 148, GRCh38.hg38 version). To our knowledge, the importance of ACE2 localization on the X chromosome has not been explored previously. Often, to have two copies ameliorates the deleterious effects of X-linked diseases and, as a consequence, most X-linked syndromes produce male diseases.

Funded by Autonoma University and Hospital Clínico San Carlos (employer).

Conflict of interest: none declared.

Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors

COVID-19: the gendered impacts of the outbreak

Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations